New horizons in the treatment of psoriasis and cutaneous fungal infections.
This article takes a historical perspective and makes an assessment of current and future changes in the treatment of psoriasis and cutaneous fungal infections. Both medical and physical therapies in the management of psoriasis are reviewed and an assessment of the new approaches, compared with the old, is made. The vexing problem of cutaneous fungal infections is considered and the newer topical preparations are reviewed. With the arrival of these newer products improved outcomes for psoriasis and cutaneous fungal infections are being found.
Cowen
P
P
Dermatology, Monash University.
D000935:Antifungal Agents / Q000008:administration & dosage*; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives; D003879:Dermatologic Agents / Q000008:administration & dosage*; D003881:Dermatomycoses / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000935:Antifungal Agents; D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol